BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11530830)

  • 1. The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone.
    Loizou GD; Cocker J
    Hum Exp Toxicol; 2001 Jul; 20(7):321-7. PubMed ID: 11530830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
    Tanaka E
    Hum Exp Toxicol; 2001 Aug; 20(8):381-5. PubMed ID: 11727787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robustness of chlorzoxazone as an in vivo measure of cytochrome P450 2E1 activity.
    Ernstgård L; Warholm M; Johanson G
    Br J Clin Pharmacol; 2004 Aug; 58(2):190-200. PubMed ID: 15255802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats.
    Mizuno D; Tanaka E; Tanno K; Misawa S
    Arch Toxicol; 2000 May; 74(3):139-44. PubMed ID: 10876999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
    Baek HW; Bae SK; Lee MG; Sohn YT
    J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low doses of nicotine and ethanol induce CYP2E1 and chlorzoxazone metabolism in rat liver.
    Howard LA; Micu AL; Sellers EM; Tyndale RF
    J Pharmacol Exp Ther; 2001 Nov; 299(2):542-50. PubMed ID: 11602665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorzoxazone metabolism by winter flounder liver microsomes: evidence for existence of a CYP2E1-like isoform in teleosts.
    Wall KL; Crivello J
    Toxicol Appl Pharmacol; 1998 Jul; 151(1):98-104. PubMed ID: 9705891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic disposition of the cytochrome P450 2E1 marker chlorzoxazone and its hydroxylated metabolite in isolated perfused rat livers.
    Mehvar R; Vuppugalla R
    J Pharm Sci; 2006 Jul; 95(7):1414-24. PubMed ID: 16724323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats.
    Jin L; Baillie TA
    Chem Res Toxicol; 1997 Mar; 10(3):318-27. PubMed ID: 9084912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats.
    Shaik IH; Mehvar R
    J Pharm Sci; 2011 Dec; 100(12):5281-92. PubMed ID: 21780121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic.
    Yang CS; Chhabra SK; Hong JY; Smith TJ
    J Nutr; 2001 Mar; 131(3s):1041S-5S. PubMed ID: 11238812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotyping of cytochrome P450 2E1 in vitro and in vivo.
    Ernstgård L; Johanson G; Karlsson AS; Warholm M
    Curr Drug Metab; 2007 Jun; 8(5):493-8. PubMed ID: 17584020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
    Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
    Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
    Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
    Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of piperine on CYP2E1 enzyme activity of chlorzoxazone in healthy volunteers.
    Bedada SK; Boga PK
    Xenobiotica; 2017 Dec; 47(12):1035-1041. PubMed ID: 27670974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels.
    Jung HY; Kang HE; Choi YH; Kim SH; Lee MG
    Biopharm Drug Dispos; 2009 Nov; 30(8):485-93. PubMed ID: 19753555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of structural analogs of diallyl sulfide as novel CYP2E1 inhibitors for their protective effect against xenobiotic-induced toxicity and HIV replication.
    Rahman MA; Gong Y; Kumar S
    Toxicol Lett; 2018 Aug; 292():31-38. PubMed ID: 29694836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity.
    Dreisbach AW; Ferencz N; Hopkins NE; Fuentes MG; Rege AB; George WJ; Lertora JJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):498-505. PubMed ID: 7586943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.